Search Login Register

Platelet Activating Factor Summary

Description: A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.

Also Known As: 1-Alkyl-2-acetyl-sn-glycerophosphocholine; Platelet Aggregating Factor; Platelet Aggregation Enhancing Factor; Platelet-Activating Substance; Thrombocyte Aggregating Activity Show All >>

Networked: 2613 relevant articles (62 outcomes, 265 trials/studies) for this Bio-Agent

Key Diseases for which Platelet Activating Factor is Relevant

  1. Asthma (Bronchial Asthma) : 8 outcomes 11 studies in 192 results
  2. Anaphylaxis (Anaphylactic Shock) : 5 outcomes 13 studies in 170 results
  3. Ischemia : 4 outcomes 17 studies in 114 results
  4. Pancreatitis : 4 outcomes 17 studies in 60 results
  5. Shock : 4 outcomes 13 studies in 139 results
Show All >>

Drugs Related to Platelet Activating Factor

  1. Histamine (Histamine Dihydrochloride)
  2. WEB 2086 (apafant)
  3. epiyangambin
  4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  5. Platelet Activating Factor
  6. Antigens
  7. Arachidonic Acid (Vitamin F)
  8. TCV 309
  9. Carrageenan
  10. CV 6209
Show All >>

Therapies Related to Platelet Activating Factor

  1. Resuscitation
  2. Intravenous Injections
  3. Injections
  4. Aftercare (After-Treatment)
  5. Homologous Transplantation (Allograft)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.